[1] ZHANG N,WANG L,DENG X,et al.Recent advances in the detection of respiratory virus infection in humans[J].J Med Virol,2020,92(4):408-417.
[2] HUANG P,WANG H,CAO Z,et al.A Rapid and Specific Assay for the Detection of MERS-CoV[J].Front Microbiol,2018,9:1101.
[3] LU R,ZHAO X,LI J,et al.Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding[J].Lancet,2020,395(10224):565-574.
[4] XU X,CHEN P,WANG J,et al.Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J].Sci China Life Sci,2020,63(3):457-460.
[5] HUI D S,AZHAR E I,MADANI T A,et al.The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan,China[J].Int J Infect Dis,2020,91:264-266.
[6] ZHU N,ZHANG D,WANG W,et al.A Novel Coronavirus from Patients with Pneumonia in China,2019[J].N Engl J Med,2020,382(8):727-733.
[7] CHEN Y,LIU Q,GUO D.Emerging coronaviruses:Genome structure,replication,and pathogenesis[J].J Med Virol,2020,92(4):418-423.
[8] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组.新型冠状病毒肺炎流行病学特征分析[J].中华流行病学杂志,2020,41(2):145-151.
[9] LAI C C,SHIH T P,KO W C,et al.Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) and coronavirus disease-2019(COVID-19):The epidemic and the challenges[J].Int J Antimicrob Agents,2020,55(3):105924.
[10] ZHOU P,YANG X L,WANG X G,et al.A pneumonia outbreak associated with a new coronavirus of probable bat origin[J].Nature,2020,579(7798):270-273.
[11] CHEN L,LIU W,ZHANG Q,et al.RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak[J].Emerg Microbes Infect,2020,9(1):313-319.
[12] ZHANG L,SHEN F M,CHEN F,et al.Origin and evolution of the 2019 novel coronavirus[J].Clin Infect Dis,2020,71(15):882-883.
[13] LIU S,XIAO G,CHEN Y,et al.Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus:implications for virus fusogenic mechanism and identification of fusion inhibitors[J].Lancet,2004,363(9413):938-947.
[14] KUHN J H,LI W,CHOE H,et al.Angiotensin-converting enzyme 2:a functional receptor for SARS coronavirus[J].Cell Mol Life Sci,2004,61(21):2738-2743.
[15] BAO L,DENG W,HUANG B,et al.The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice[J].Nature,2020,583(7818):830-833.
[16] HAMMING I,TIMENS W,BULTHUIS M L,et al.Tissue distribution of ACE2 protein,the functional receptor for SARS coronavirus.A first step in understanding SARS pathogenesis[J].J Pathol,2004,203(2):631-637.
[17] NEUMAN B W,KISS G,KUNDING A H,et al.A structural analysis of M protein in coronavirus assembly and morphology[J].J Struct Biol,2011,174(1):11-22.
[18] SCHOEMAN D,FIELDING B C.Coronavirus envelope protein:current knowledge[J].Virol J,2019,16(1):69.
[19] LIU C,KOKUHO T,KUBOTA T,et al.DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus[J].Virus Res,2001,80(1-2):75-82.
[20] 国家卫生健康委员会,国家中医药管理局.新型冠状病毒肺炎诊疗方案(试行第七版)[J].江苏中医药,2020,52(4):1-6.
[21] ZHANG B,ZHOU X,ZHU C,et al.Immune phenotyping based on neutrophil-to-lymphoyte ratio and IgG predicts disease severity and outcome for patients with COVID-19[J].Front Mol Biosci,2020,7:157.
[22] CHEN G,WU D,GUO W,et al.Clinical and immunological features of severe and moderate coronavirus disease 2019[J].J Clin Invest,2020,130(5):2620-2629.
[23] 冯燕,卢亦愚,严菊英,等.荧光定量RT-PCR技术快速检测SARS病毒核酸[J].中国病毒学,2005(3):228-231.
[24] WU F,ZHAO S,YU B,et al.A new coronavirus associated with human respiratory disease in China[J].Nature,2020,579(7798):265-269.
[25] DI L,FU Y,SUN Y,et al.RNA sequencing by direct tagmentation of RNA/DNA hybrids[J].Proc Natl Acad Sci U S A,2020,117(6):2886-2893.
[26] NOTOMI T,OKAYAMA H,MASUBUCHI H,et al.Loop-mediated isothermal amplification of DNA[J].Nucleic Acids Res,2000,28(12):E63.
[27] TOMITA N,MORI Y,KANDA H,et al.Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products[J].Nat Protoc,2008,3(5):877-882.
[28] CRAW P,BALACHANDRAN W.Isothermal nucleic acid amplification technologies for point-of-care diagnostics:a critical review[J].Lab Chip,2012,12(14):2469-2486.
[29] NAGAMINE K,HASE T,NOTOMI T.Accelerated reaction by loop-mediated isothermal amplification using loop primers[J].Mol Cell Probes,2002,16(3):223-229.
[30] HUANG W E,LIM B,HSU C C,et al.RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2[J].Microb Biotechnol,2020,13(4):950-961.
[31] PARK G S,KU K,BAEK S H,et al.Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2)[J].J Mol Diagn,2020,22(6):729-735.
[32] 崔尚金,梁琳,贾亚雄,等.新型冠状病毒可视化恒温快速检测试剂盒:CN110982944A[P].2020-03-03.
[33] LIU R,HAN H,LIU F,et al.Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan,China,from Jan to Feb 2020[J].Clin Chim Acta,2020,505:172-175.
[34] HOU Y J,OKUDA K,EDWARDS C E,et al.SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract[J].Cell,2020,182(2):429-446.
[35] HSUEH P R,HUANG L M,CHEN P J,et al.Chronological evolution of IgM,IgA,IgG and neutralisation antibodies after infection with SARS-associated coronavirus[J].Clin Microbiol Infect,2004,10(12):1062-1066.
[36] XU X,SUN J,NIE S,et al.Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China[J].Nat Med,2020,26(8):1193-1195.
[37] 邹明园,吴国球.抗原交叉反应对新型冠状病毒血清特异性抗体检测的影响[J].临床检验杂志,2020,38(3):161-163.
[38] WU F,WANG A,LIU M,et al.Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications(2020-03-28)[EB/OL].https://ssrn.com/abstract=3566211.
[39] LI Z,YI Y,LUO X,et al.Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis[J].J Med Virol,2020,92(9):1518-1524.
[40] ZHAO J,YUAN Q,WANG H,et al.Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019[J].Clin Infect Dis,2020.Online ahead of print.
[41] JIN Y H,CAI L,CHENG Z S,et al.A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)[J].Mil Med Res,2020,7(1):4.
[42] PAN Y,GUAN H,ZHOU S,et al.Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV):a study of 63 patients in Wuhan,China[J].Eur Radiol,2020,30(6):3306-3309.
[43] 江苏省新型冠状病毒感染肺炎医学影像学检查、诊断与防控规范专家共识(2020年第1版)[J].东南大学学报(医学版),2020,39(2):121-139.
[44] XIONG Y,SUN D,LIU Y,et al.Clinical and High-Resolution CT Features of the COVID-19 Infection:Comparison of the Initial and Follow-up Changes[J].Invest Radiol,2020,55(6):332-339.
[45] 施绍瑞,聂滨,郭渝,等.新型冠状病毒肺炎病例多种生物样本的病毒核酸检测结果[J].华西医学,2020,35(2):132-136.
[46] 徐万洲,李娟,何晓云,等.血清2019新型冠状病毒IgM和IgG抗体联合检测在新型冠状病毒感染中的诊断价值[J].中华检验医学杂志,2020,43(3):230-233.
[47] LI H,PAN J,SU Y,et al.SARS-CoV-2 lgM/lgG antibody detection confirms the infection after three negative nucleic acid detection[J].J Cell Mol Med,2020,24(14):8262-8265.
[48] TON A T,GENTILE F,HSING M,et al.Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds[J].Mol Inform,2020,39(8):2000028.
[49] GURWITZ D.Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics[J].Drug Dev Res,2020,81(5):537-540.
[50] TIAN X,LI C,HUANG A,et al.Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody[J].Emerg Microbes Infect,2020,9(1):382-385.
[51] TOMAR S,MALIK Y S,CHOUDHARY S.Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in Silico Structure-Based Virtual Screening Approach[J].Front Immunol,2020,11:1664.
[52] 赵天宇,王小.研发新冠疫苗全球96个团队赛跑[J].科学大观园,2020(7):34-35.
[53] ZHENG Y,LI R,LIU S.Immunoregulation with mTOR inhibitors to prevent COVID-19 severity:A novel intervention strategy beyond vaccines and specific antiviral medicines[J].J Med Virol,2020,92(9):1495-1500.
[54] GORDON D E,JANG G M,BOUHADDOU M,et al.A SARS-CoV-2 protein interaction map reveals targets for drug repurposing[J].Nature,2020,583(7816):459-468.
[55] ZHOU Y,HOU Y,SHEN J,et al.Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2[J].Cell Discov,2020,6:14. |
